You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 7,511,131


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,511,131 protect, and when does it expire?

Patent 7,511,131 protects KYNAMRO and is included in one NDA.

This patent has forty-five patent family members in eleven countries.

Summary for Patent: 7,511,131
Title:Antisense modulation of apolipoprotein B expression
Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for treatment of diseases associated with expression of apolipoprotein B are provided.
Inventor(s): Crooke; Roseanne M. (Carlsbad, CA), Graham; Mark (San Clemente, CA), Freier; Susan M. (San Diego, CA)
Assignee: Genzyme Corporation (Cambridge, MA)
Application Number:10/712,795
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,511,131
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,511,131: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article provides a detailed analysis of the scope and claims of United States Patent 7,511,131, along with an overview of the patent landscape.

Background of U.S. Patent 7,511,131

To begin, it is essential to identify the patent in question. However, since the specific details of U.S. Patent 7,511,131 are not provided in the sources, we will use general principles and tools to analyze its scope and claims.

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the language of the claims, which are the legally binding descriptions of the invention[3].

Metrics for Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can indicate the complexity and breadth of the invention. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Analyzing Claims

To analyze the claims of U.S. Patent 7,511,131, one would typically start by reading the independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Tools for Patent Analysis

USPTO Patent Public Search

The USPTO provides several tools for searching and analyzing patents. The Patent Public Search tool is a powerful resource that allows users to search through issued and published patents, including the ability to view the full text of the patent and its claims[4].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices. This can be useful in understanding the patent family and any office actions related to the patent[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing the search results for the same invention produced by several offices on a single page[4].

Steps to Analyze U.S. Patent 7,511,131

Step 1: Locate the Patent

Use the USPTO Patent Public Search tool to locate U.S. Patent 7,511,131. This will provide access to the full text of the patent, including the claims, description, and drawings.

Step 2: Read the Claims

Carefully read the independent and dependent claims to understand the scope of the invention. Identify key elements and limitations that define the invention.

Step 3: Analyze Claim Language

Use metrics such as independent claim length and count to gauge the breadth of the patent. Narrower claims generally indicate a more focused invention, while broader claims may suggest a wider scope of protection[3].

Step 4: Review Prior Art and Office Actions

Utilize the Global Dossier and CCD tools to review prior art and any office actions related to the patent. This can provide insights into how the patent office viewed the invention during the examination process[4].

Step 5: Examine Patent Family

Identify any continuation-in-part, continuation, or divisional patents related to U.S. Patent 7,511,131. This can help in understanding the broader patent landscape and any potential extensions or limitations of the original patent[1].

Patent Landscape

Related Patents

Determine if there are other patents in the same family or related to U.S. Patent 7,511,131. This can include continuations-in-part, continuations, or divisional patents. For example, in the case of Cellect LLC, multiple patents were part of the same family and claimed priority from a single application[1].

Competitor Patents

Search for patents held by competitors in the same field. This can be done using the USPTO Patent Public Search tool or by searching international patent databases such as those provided by the European Patent Office (EPO) or the World Intellectual Property Organization (WIPO)[4].

Litigation and Enforcement

Check if there have been any litigation or enforcement actions related to U.S. Patent 7,511,131. This can provide insights into how the patent has been defended or challenged in court.

Practical Considerations

Patent Term Adjustment (PTA)

Understand any Patent Term Adjustments (PTA) that may have been granted due to delays in the prosecution process. PTA can extend the term of the patent beyond its normal expiration date[1].

Terminal Disclaimers

Determine if any terminal disclaimers have been filed to overcome obviousness-type double patenting (ODP) rejections. Terminal disclaimers can affect the patent term and are often used to resolve ODP issues[1].

Key Takeaways

  • Patent Scope: The scope of a patent is defined by its claims, with narrower claims generally indicating a more focused invention.
  • Claim Analysis: Independent and dependent claims must be carefully read to understand the invention's boundaries.
  • Tools and Resources: The USPTO provides several tools, including Patent Public Search, Global Dossier, and CCD, to aid in patent analysis.
  • Patent Landscape: Understanding related patents, competitor patents, and any litigation or enforcement actions is crucial for a comprehensive analysis.
  • Practical Considerations: Factors such as PTA and terminal disclaimers can impact the patent's term and validity.

FAQs

Q: How do I locate a specific patent using USPTO tools?

A: You can use the USPTO Patent Public Search tool to locate a specific patent by entering the patent number or other relevant search terms.

Q: What is the difference between independent and dependent claims?

A: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Q: How can I determine the scope of a patent?

A: The scope of a patent is determined by the language of its claims. Metrics such as independent claim length and count can also provide insights into the patent's breadth.

Q: What is Patent Term Adjustment (PTA), and how does it affect a patent?

A: PTA extends the term of a patent due to delays in the prosecution process caused by the USPTO. It ensures that the patent holder receives the full term of protection despite delays.

Q: Why are terminal disclaimers important in patent law?

A: Terminal disclaimers are used to overcome obviousness-type double patenting (ODP) rejections and can affect the patent term by ensuring that the patent does not extend beyond the date of a terminal disclaimer.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent Small Claims Court, Administrative Conference of the United States.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Search for Patents, United States Patent and Trademark Office.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,511,131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kastle Theraps Llc KYNAMRO mipomersen sodium SOLUTION;SUBCUTANEOUS 203568-001 Jan 29, 2013 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.